YDYi Ding

Yi Ding

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yi Ding has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Yujiao Yang

    Department of Geriatrics, The Third Affiliated Hospital of Soochow University (The First People’s Hospital of Changzhou), Changzhou, China

    4 shared publications
  • Fenfen Liu

    Department of Geriatrics, The Third Affiliated Hospital of Soochow University (The First People’s Hospital of Changzhou), Changzhou, China

    3 shared publications
  • Long Wang

    Department of Geriatrics, The Third Affiliated Hospital of Soochow University (The First People’s Hospital of Changzhou), Changzhou, China

    3 shared publications
  • Ping Liu

    Department of Geriatrics, The Third Affiliated Hospital of Soochow University (The First People’s Hospital of Changzhou), Changzhou, China

    3 shared publications
  • Ruoling Teng

    Department of Geriatrics, The Third Affiliated Hospital of Soochow University (The First People’s Hospital of Changzhou), Changzhou, China

    3 shared publications
  • Cuiping Zhang

    Department of Geriatrics, The First People's Hospital of Changzhou (The Third Affiliated Hospital of Soochow University), Changzhou 213000, Jiangsu, China

    2 shared publications

Latest Publications

  • Open Access

    Association between triglyceride-glucose index and early vascular aging in patients with type 2 diabetes mellitus: a retrospective cross-sectional study

    by Qi Fu, Yujiao Yang, Fenfen Liu, Long Wang, Ruoling Teng, Jiao Wang, Ping Liu, Yanan Chen, Yi Ding

    Early vascular aging (EVA) is a key contributor to the elevated risk of cardiovascular disease, which remains a leading cause of mortality and disability in patients with type 2 diabetes mellitus (T2DM). This study aims to investigate the association between the triglyceride-glucose (TyG) index and EVA in T2DM patients. T2DM patients were enrolled, and their clinical data were collected. Bilateral brachial-ankle pulse wave velocity (baPWV) was measured and used to determine the presence of EVA. Binary logistic regression analysis was conducted to evaluate the effect of the TyG index and identify factors associated with EVA. A predictive model was constructed using a nomogram, and its performance was assessed using receiver operating characteristic (ROC) curve analysis. A total of 380 patients were included in the study, among whom 144 (37.89%) were identified as having EVA. After adjusting for all relevant covariates, the TyG index remained independently and positively associated with EVA (odds ratio [OR] = 2.76, 95% confidence interval [CI]: 1.57–4.85), patients in the highest TyG tertile had a 4.30-fold increased risk of developing EVA compared to those in the lowest tertile (95% CI: 1.97–9.42). Elevated TyG index (OR = 2.53, 95% CI: 1.79–3.57) and systolic blood pressure (OR = 1.04, 95% CI: 1.02–1.06) were positively associated with EVA in T2DM patients, while male sex (OR = 0.50, 95% CI: 0.30–0.83) and absence of T2DM complications (OR = 0.56, 95% CI: 0.34–0.92) were negatively associated with EVA. Based on these findings, a predictive model was developed, which demonstrated good discrimination with an area under the ROC curve (AUC) of 0.776 (95% CI: 0.728–0.824). A higher TyG index and elevated systolic blood pressure were independently associated with the presence of EVA, whereas male sex and the absence of T2DM complications were associated with a lower likelihood of its occurrence. These findings provide valuable insights for the early identification of high-risk individuals.


  • Open Access

    Correlation study of multiple inflammatory indices and vertebral compression fracture: A cross-sectional study

    by Qi Fu, Cuiping Zhang, Yujiao Yang, Ruoling Teng, Fenfen Liu, Ping Liu, Long Wang, Jiao Wang, Yanan Chen, Yi Ding


  • Open Access

    Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy

    by Yujiao Yang, Ping Liu, Ruoling Teng, Fenfen Liu, Cuiping Zhang, Xiang Lu, Yi Ding

    Background: Dilated cardiomyopathy (DCM) is currently the major cause of systolic heart failure. This study explored potential therapeutic targets and investigated the role of immune cell infiltration in DCM. Methods: Three DCM datasets (GSE3585, GSE9800, and GSE84796) from the Gene Expression Omnibus (GEO) database were merged into an integrated dataset, and batch effects were removed. Differentially expressed genes (DEGs) were screened and the associations between gene co-expression modules and clinical traits were assessed by weighted gene co-expression network analysis (WGCNA) in R software. Any DEGs from the integrated dataset overlapped with the significant module genes were defined as common genes (CGs). Enrichment analysis of the CGs was performed. The protein-protein interaction (PPI) network of the CGs was visualized and the hub gene was identified by using Cytoscape 3.8.2 software. The miRNA-transcription factor-mRNA (miRNA-TF-mRNA) network was constructed using Cytoscape to unveil the regulatory relationships in DCM. Finally, the CIBERSORT method (https://cibersort.stanford.edu/) was used to investigate immune cell infiltration in DCM. Results: A total of 53 DEGs were identified, and 5 gene co-expression modules were detected by WGCNA of the DCM and control group samples of cardiac tissue. Genes such as FRZB, ASPN, and PHLDA1 were significantly upregulated, whereas IDH2 and ENDOG were significantly downregulated. Functional enrichment analysis showed that CGs were mainly enriched in the extracellular matrix (ECM) signaling pathway. ASPN was the hub gene in the PPI network. The miRNA-TF-mRNA network revealed that FRZB and ASPN were targeted by paired related homeobox 2 (Prrx2). We also found that miR-129-5p could regulate ASPN, PHLDA1, and IDH2 simultaneously. The immune infiltration analysis revealed higher levels of M1 macrophages in DCM samples than in the control samples. Conclusions: In conclusion, we speculate that miR-129-5p might target ASPN in regulating DCM via the ECM signaling pathway. Macrophage infiltration may be involved in ECM remodeling and eventually lead to DCM.


  • Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies

    by Bo Guan, Xintao Li, Wenqiang Xue, Gary Tse, Khalid Bin Waleed, Yichen Liu, Mengyi Zheng, Shouling Wu, Yunlong Xia, Yi Ding


  • Open Access

    Lack of association between interleukin-1 receptor antagonist gene 86-bp VNTR polymorphism and ischemic stroke

    by Yujiao Yang, Wenhui Wu, Long Wang, Yi Ding

    The results of published studies which examined the association between variable number tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL-1RN) and ischemic stroke (IS) are conflicting. Thus, we performed a meta-analysis to examine the potential association between IL-1RN VNTR polymorphism and IS risk. A systematic literature search of PubMed, Embase, Medline, Web of Science, Cochrane Library, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, CQVIP, and WANFANG Database identified 10 studies with 2331 cases and 3335 controls. The pooled odds ratio (OR) with 95% confidence interval (95% CI) was calculated to evaluate the strength of the association. Subgroup analysis and meta-regression analysis were used to investigate the potential sources of heterogeneity. Begg funnel plots were used to explore the publication bias. In this study, no enough proof was found to prove the association between IL-1RN 86-bp VNTR polymorphism and IS risk with random-effects model in the homozygous model (1/1 vs 2/2, OR = 0.97, 95% CI = 0.50–1.87, Pheterogeneity = .00), the heterozygous model (1/2 vs 2/2, OR = 0.64, 95% CI = 0.41–1.01, Pheterogeneity = .10), the dominant model (1/1 + 1/2 vs 2/2, OR = 0.85, 95% CI = 0.51–1.42, Pheterogeneity = .02), the recessive model (1/1 vs 1/2 + 2/2, OR = 0.69, 95% CI = 0.46–1.03, Pheterogeneity = .00), and allelic model (1 vs 2, OR = 1.24, 95% CI = 0.89–1.74, Pheterogeneity = .00). A marginally significant negative association was observed between IL-1RN 86-bp VNTR polymorphism and IS risk in the heterozygous model in the fixed-effects model (1/2 vs 2/2, OR = 0.71, 95% CI = 0.53–0.95, Pheterogeneity = .10). In subgroup analyses, similar association was found in the group whose control size was lower than 300. In conclusion, our results suggested that there was no sufficient evidence to support the association between IL-1RN 86-bp VNTR polymorphism and IS. Further large epidemiologic studies need to be done to confirm these findings.